UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000011552
Receipt No. R000013517
Scientific Title Phase II study of XELOX plus bevacizumab as second-line chemotherapy prior oral fluoropyrimidine, irinotecan plus bevacizmab for metastatic colorectal cancer
Date of disclosure of the study information 2013/08/22
Last modified on 2016/11/16 09:05:53

No. Disposal Last modified on Item of update
1 Insert 2013/08/22 17:10:37
2 Update 2016/06/28 12:36:45 UMIN ID1
3 Update 2016/11/16 09:04:41 Control
Key inclusion criteria
4 Update 2016/11/16 09:05:31 Email
Name of person sending information
Name of person sending information
Email
Name of primary sponsor
Organization
5 Update 2016/11/16 09:05:53 Recruitment status


Contact us.